Aspiration and Biopsy Needles Market by Product (Fine Needle Aspiration and Biopsy Needles), Procedure (Image Guided and Non-Image Guided), End-Users (Hospitals, Ambulatory Surgical Centers, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026786 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 1.16 billion in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 6.6% during the forecast period

The image-guided procedures segment is growing mainly attributed to a wide scope of application

Image-guided procedures such as ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other image-guided procedures accounted the largest share of this market mainly due to the rising preference for minimally invasive biopsy and aspiration procedure. Due to growing demand operating companies are developing new products. For instance, in November 2019, GE Healthcare introduced Serena Bright, the healthcare industry’s first contrast-enhanced mammography solution for biopsy. This new mammography-guided biopsy technique offers an alternative to MR-guided breast biopsy, which can improve the patient experience and allow faster diagnosis capabilities.

Within the report, the market is segmented into product, procedure, end-users, and geography. Based on product, the global aspiration and biopsy needles market is bifurcated into fine needle aspiration and biopsy needles. Based on procedure, the market is divided into image guided and non-image guided. Based on end-users, the global aspiration and biopsy needles market is segmented into hospitals, ambulatory surgical centers, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Increasing public–private investments, grants, and funds

In the last few years, there has been an increase in investments for research activities focused on the early detection of breast cancer. For instance, in the January 2020, Jiangsu Yucheng, a leading Chinese investment enterprise, invested in PA Imaging in the Netherlands, to validate its photo-acoustic mammography product with a cross-over clinical study, with the ultimate aim to obtain CE marking.

The Society of Breast Imaging in the US focuses on minimizing the impact of breast cancer and saving lives of the patients. It has a Research & Education Fund program that aims at providing funds to support the research and education for breast imaging. Further, in US, the Mayo Mammography Health Study was launched in 2003 with the help of the funding provided by the National Cancer Institute (NCI). The research team continues to receive NCI funding for their research on mammography, breast density, and breast cancer.

Increasing prevalence of cancer

Cancer is a leading cause of death worldwide. According to the World Health Organization (WHO), cancer was the first leading cause of death in the people of age below 70 years in 183 countries and the fourth leading cause of death among the population of all ages in 123 countries worldwide in 2019. In addition, as per the data published by the WHO in March 2021, different cancer types caused ~10 million deaths in 2020. The increasing prevalence of cancer has created a burden on healthcare systems across the world, along with bolstering the demand for chemotherapy. The high prevalence of CIPN raises concerns about cancer patients and survivors, and their healthcare providers, especially because there is no single effective way to prevent CIPN.

Recent strategic developments in the aspiration and biopsy needles market

The aspiration and biopsy needles market has undergone several significant developments, and a few of these have been mentioned below:

  • In June 2022, GE Healthcare unveiled the new Allia platform for minimally invasive, image-guided surgery. GE Healthcare designed the platform through a multi-year collaboration with interventionists and surgeons to enhance user experience, improve workflow efficiency and increase the adoption of advanced image guidance in daily practice
  • In July 2022, BillionToOne announced the launch of its first oncology liquid biopsy products, Northstar Select and Northstar Response. The products are presently available for research use with selective academic cancer centers. Northstar Select is an exhaustive pan-cancer somatic mutation profiling panel that achieves a notable limit of detection for the designation of actionable alterations.

The aspiration and biopsy needles market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Becton, Dickinson and Company, Boston Scientific Corporation, Argon Medical, Cardinal Health, Conmed Corporation, Cook, Medtronic, Stryker, Merit Medical Systems, and Olympus Medical are among the prominent players operating in the market.

The target audience for the report:

  • Raw Material Providers
  • Associations, Organizations, Forums, And Alliances
  • Government Bodies, Such as Regulating Authorities and Policymakers
  • Hospital Settings
  • Diagnostic Laboratories
  • Clinics
  • Research Laboratories
  • Venture Capitalists, Private Equity Firms, and Start-Up Companies
  • Research Institutes, Organizations, and Consulting Companies

Scope of the report:

In this report, the market has been segmented based on:

  • Product:
  • Fine Needle Aspiration
  • Biopsy Needles
  • Procedure:
  • Image Guided
  • Non-Image Guided
  • End-Users:
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • South & Central America
    • Middle East & Africa
  • Companies Profiled
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Argon Medical
    • Cardinal Health
    • Conmed Corporation
    • Cook
    • Medtronic
    • Stryker
    • Merit Medical Systems
    • Olympus Medical

The List of Companies
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Argon Medical
- Cardinal Health
- Conmed Corporation
- Cook
- Medtronic
- Stryker
- Merit Medical Systems
- Olympus Medical

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000